Inari Medical (NARI) DOJ Investigation Case

The defendant has requested the court to dismiss the case.

S.D. New York

Court

1:24-cv-03686

Case number

02/24/2022

Class period Start

02/28/2024

Class period End

07/12/2024

Lead Plaintiff motion deadline

$NARI stockholder filed a claim vs. Inari Medical for hiding improper payments to medical professionals and engagement in illegal practices.
On February 28, 2024, the news about a DOJ investigation caused $NARI to fall 20%, losing $705M+ in shareholder value.
Affected $NARI investors may join the claim to be notified about potential recovery.
On February 28, 2024, Inari revealed a DOJ investigation into payments to healthcare professionals, focusing on potential violations of the Anti-Kickback Statute and Civil False Claims Act.

After this news, $NARI plummeted over 21% the next day.

Based on these events, $NARI stockholder filed a claim against Inari Medical and its leaders, accusing them of the following:
Inari claimed record revenue from its core VTE business but hid improper payments to medical professionals.
Inari engaged in illegal business practices, violating the federal Anti-Kickback Statute and Civil False Claims Act.
Considering all the representations, investors have reasons to suspect that Inari Medical hid improper payments to medical professionals and engaged in illegal practices.

One of $NARI investors has already filed a claim vs. Inari Medical in the S. D. of New York court.

Case Type

US Securities Class Action

Case Status

Motion to dismiss

Alleged Offence

Mismanagement,

Misleading Statements,

Omissions

Suspected Party

Directors,

Management

Security Type

Stocks

Trade Direction

Long

Shock Event Date

02/29/2024

Filing date

05/13/2024

Lead Plaintiff Deadline

07/12/2024

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.